Skip to main content


Latest articles

22-11-2019 | Diabetes | News | Article

Add-on liraglutide benefits overweight insulin pump users with poor glycemic control

Adding liraglutide to continuous subcutaneous insulin infusion significantly reduces glycated hemoglobin without increasing hypoglycemia in overweight and obese people with type 1 diabetes and suboptimal glycemic control, Danish research shows.

21-11-2019 | Diabetes | News | Article

Glycated hemoglobin variability between clinic visits linked to adverse events

Frequent fluctuations in glycated hemoglobin levels between clinic visits are associated with death, cardiovascular disease, and microvascular complications in patients newly diagnosed with type 2 diabetes, a Scottish study suggests.

19-11-2019 | Diabetes | News | Article

Dapagliflozin improves life quality for people with heart failure

Dapagliflozin treatment significantly improves self-reported symptoms, physical function, and quality of life in people who have heart failure with reduced ejection fraction, report the DAPA-HF investigators.

19-11-2019 | Diabetes | News | Article

Support for add-on dapagliflozin use in HF patients of all ages

A post-hoc analysis of data from the DAPA-HF trial indicates that the sodium-glucose cotransporter 2 inhibitor dapagliflozin has consistent efficacy and safety profiles among people with heart failure and reduced ejection fraction across a range of age categories.

18-11-2019 | Diabetes | News | Article

Fasting plasma glucose predicts adverse pregnancy outcome better than post-load glucose

Elevated fasting plasma glucose is associated with a higher risk for babies born large‐for‐gestational‐age and for hypertensive disorders of pregnancy than elevated post‐load glucose in women with gestational diabetes, population-based study data show.

14-11-2019 | Diabetes | News | Article

Islet autoantibody negativity, mild hyperglycemia should trigger MODY genetic screening

Islet autoantibody negativity plus mild hyperglycemia and a family history of diabetes can be used to identify children newly diagnosed with diabetes who should undergo genetic testing for maturity-onset diabetes of the young, study findings indicate.

13-11-2019 | Diabetes | News | Article

Hyperglycemic crisis combination linked with hospital deaths

A study of more than a thousand patients suggests that having both diabetic ketoacidosis and a hyperosmolar hyperglycemic state on arrival at hospital leads to more than twice the likelihood of death there than either condition alone.

11-11-2019 | Diabetes | News | Article

Online coaching helps with weight loss maintenance

People who are trying to maintain weight loss with the help of electronic health records-based tracking tools do significantly better if they are given access to an online coach, shows a randomized trial.

08-11-2019 | Diabetes | News | Article

VITAL-DKD: No benefits of vitamin D, omega-3 in diabetic kidney disease

Neither vitamin D nor omega-3 fatty acids are able to slow the decline in kidney function for people with type 2 diabetes, show the results of the VITAL-DKD trial.

08-11-2019 | Diabetes | News | Article

Student mentoring of teens with diabetes produces all-round gains

Assigning student mentors to teenagers with type 1 diabetes and low socioeconomic status brings a variety of benefits to both mentors and mentees, show the results of a US pilot study.

07-11-2019 | Diabetes | News | Article

Echocardiography refines cardiovascular risk in type 1 diabetes

Routine echocardiographic measures of myocardial dysfunction improve on the ability of clinical risk factors to predict major adverse cardiovascular events in people with type 1 diabetes, say researchers.

07-11-2019 | Diabetes | News | Article

Detection bias may contribute to reduced prostate cancer risk in diabetes

The reduced prostate cancer risk seen in men with diabetes may be partly explained by detection bias due to a lower biopsy rate following an elevated prostate-specific antigen test result, population-based study data show.

05-11-2019 | Diabetes | News | Article

Breastfeeding study informs on insulin pump settings after childbirth

A small Danish study in breastfeeding women with long-term type 1 diabetes could provide useful information on which insulin pump settings to use after childbirth.

05-11-2019 | Diabetes | News | Article

Group medical visits may be more effective with added intensive weight management

Adding intensive weight management to group medical visits for type 2 diabetes leads to greater weight loss, reduced medication use, and fewer hypoglycemic events, with a similar improvement in glycemic control, research shows.

01-11-2019 | Diabetes | News | Article

Cannabis use may raise DKA risk in people with type 1 diabetes

Findings from the T1D Exchange clinic registry suggest a more than twofold increased risk for diabetic ketoacidosis in people who are moderate users of cannabis.

01-11-2019 | Diabetes | News | Article

Treatment-resistant hypertension predicts CV events in type 2 diabetes

Apparent treatment-resistant hypertension may help identify patients with type 2 diabetes who are at elevated cardiovascular risk, say researchers, but ambulatory blood pressure should still be performed for comprehensive risk stratification.

31-10-2019 | Diabetes | News | Article

Trial results support gastric bypass as ‘procedure of choice’ for diabetes remission

People with obesity and type 2 diabetes who undergo gastric bypass surgery have higher rates of diabetes remission after 1 year than those undergoing sleeve gastrectomy, indicate findings from the Oseberg trial.

29-10-2019 | Diabetes | News | Article

Adult-onset type 1 diabetes may benefit from more intense monitoring in the early days

Research suggests that individuals with adult-onset type 1 diabetes could benefit from more intense monitoring, as only a minority meet recommended targets for glycemic control despite initial improvements, while at the same time the majority become overweight or obese.

28-10-2019 | Diabetes | News | Article

Long-term metformin use may reduce heart failure risk

Study results suggest that prolonged use of metformin by people with type 2 diabetes may reduce their risk for being hospitalized with heart failure.

25-10-2019 | Diabetes | News | Article

Further support for early combination therapy in type 2 diabetes

Adding the DPP-4 inhibitor sitagliptin to first-line metformin therapy may delay the need for exogenous insulin among people with type 2 diabetes, researchers report.

Image Credits